Company / Operating Cash Flow
Nuo Therapeutics, Inc. Operating Cash Flow History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$4.9M
FY2017
5-year range
-$17.4M / -$4.9M
FY2013-FY2017
Trend
+37.4%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has increased for 3 consecutive years, from -$17M in FY2014 to -$5M in FY2017.
Based on SEC 10-K filings.
-$5M in FY2017.
Improved from -$14M to -$5M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Nuo Therapeutics, Inc.'s operating cash flow has grown for 3 consecutive years.
- In FY2017, operating cash flow increased 37.4% year-over-year.
- Peak operating cash flow was recorded in FY2011.
- Lowest operating cash flow in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$4.9M | +37.4% |
| FY2016 | -$7.8M | +45.5% |
| FY2015 | -$14.4M | +17.4% |
| FY2014 | -$17.4M | -52.8% |
| FY2013 | -$11.4M | -0.1% |
| FY2012 | -$11.4M | -168.7% |
| FY2011 | -$4.2M | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026